Selected research
Industry Research
Synthetic Bone Graft Substitute Syringe Industry Research Report 2026
Market perspective
The global Synthetic Bone Graft Substitute Syringe market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Synthetic Bone Graft Substitute Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Synthetic Bone Graft Substitute Syringe is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Synthetic Bone Graft Substitute Syringe is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Synthetic Bone Graft Substitute Syringe include Augma Biomaterials, Biomatlante, Citagenix, Collagen Matrix, DSI Dental Solutions, Nordson MEDICAL, Osteogenics Biomedical, Sunstar Americas, Inc. and TEKNIMED, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Synthetic Bone Graft Substitute Syringe market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Synthetic Bone Graft Substitute Syringe Market by Company
Augma Biomaterials
Biomatlante
Citagenix
Collagen Matrix
DSI Dental Solutions
Nordson MEDICAL
Osteogenics Biomedical
Sunstar Americas, Inc.
TEKNIMED
Synthetic Bone Graft Substitute Syringe Segment by Type
Capacity: 0.5cc
Capacity: 1.0cc
Others
Synthetic Bone Graft Substitute Syringe Segment by Application
Hospital
Ambulatory Surgery Center
Others
Synthetic Bone Graft Substitute Syringe Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Bone Graft Substitute Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Synthetic Bone Graft Substitute Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Bone Graft Substitute Syringe.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Synthetic Bone Graft Substitute Syringe manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Synthetic Bone Graft Substitute Syringe by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Synthetic Bone Graft Substitute Syringe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capacity: 0.5cc
- Capacity: 1.0cc
- Others
Applications
- Hospital
- Ambulatory Surgery Center
- Others
Companies covered
- Augma Biomaterials
- Biomatlante
- Citagenix
- Collagen Matrix
- DSI Dental Solutions
- Nordson MEDICAL
- Osteogenics Biomedical
- Sunstar Americas, Inc.
- TEKNIMED
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Synthetic Bone Graft Substitute Syringe Market Size (2021-2032)
- 2.2.2 Global Synthetic Bone Graft Substitute Syringe Sales (2021-2032)
- 2.2.3 Global Synthetic Bone Graft Substitute Syringe Market Average Price (2021-2032)
- 2.3 Synthetic Bone Graft Substitute Syringe by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capacity: 0.5cc
- 2.3.3 Capacity: 1.0cc
- 2.3.4 Others
- 2.4 Synthetic Bone Graft Substitute Syringe by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Ambulatory Surgery Center
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Synthetic Bone Graft Substitute Syringe Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Synthetic Bone Graft Substitute Syringe Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Synthetic Bone Graft Substitute Syringe Revenue of Manufacturers (2021-2026)
- 3.4 Global Synthetic Bone Graft Substitute Syringe Average Price by Manufacturers (2021-2026)
- 3.5 Global Synthetic Bone Graft Substitute Syringe Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Synthetic Bone Graft Substitute Syringe, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Synthetic Bone Graft Substitute Syringe, Product Type & Application
- 3.8 Global Manufacturers of Synthetic Bone Graft Substitute Syringe, Established Date
- 3.9 Global Synthetic Bone Graft Substitute Syringe Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Augma Biomaterials
- 4.1.1 Augma Biomaterials Company Information
- 4.1.2 Augma Biomaterials Business Overview
- 4.1.3 Augma Biomaterials Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Augma Biomaterials Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.1.5 Augma Biomaterials Recent Developments
- 4.2 Biomatlante
- 4.2.1 Biomatlante Company Information
- 4.2.2 Biomatlante Business Overview
- 4.2.3 Biomatlante Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Biomatlante Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.2.5 Biomatlante Recent Developments
- 4.3 Citagenix
- 4.3.1 Citagenix Company Information
- 4.3.2 Citagenix Business Overview
- 4.3.3 Citagenix Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Citagenix Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.3.5 Citagenix Recent Developments
- 4.4 Collagen Matrix
- 4.4.1 Collagen Matrix Company Information
- 4.4.2 Collagen Matrix Business Overview
- 4.4.3 Collagen Matrix Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Collagen Matrix Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.4.5 Collagen Matrix Recent Developments
- 4.5 DSI Dental Solutions
- 4.5.1 DSI Dental Solutions Company Information
- 4.5.2 DSI Dental Solutions Business Overview
- 4.5.3 DSI Dental Solutions Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DSI Dental Solutions Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.5.5 DSI Dental Solutions Recent Developments
- 4.6 Nordson MEDICAL
- 4.6.1 Nordson MEDICAL Company Information
- 4.6.2 Nordson MEDICAL Business Overview
- 4.6.3 Nordson MEDICAL Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nordson MEDICAL Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.6.5 Nordson MEDICAL Recent Developments
- 4.7 Osteogenics Biomedical
- 4.7.1 Osteogenics Biomedical Company Information
- 4.7.2 Osteogenics Biomedical Business Overview
- 4.7.3 Osteogenics Biomedical Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Osteogenics Biomedical Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.7.5 Osteogenics Biomedical Recent Developments
- 4.8 Sunstar Americas, Inc.
- 4.8.1 Sunstar Americas, Inc. Company Information
- 4.8.2 Sunstar Americas, Inc. Business Overview
- 4.8.3 Sunstar Americas, Inc. Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sunstar Americas, Inc. Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.8.5 Sunstar Americas, Inc. Recent Developments
- 4.9 TEKNIMED
- 4.9.1 TEKNIMED Company Information
- 4.9.2 TEKNIMED Business Overview
- 4.9.3 TEKNIMED Synthetic Bone Graft Substitute Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 TEKNIMED Synthetic Bone Graft Substitute Syringe Product Portfolio
- 4.9.5 TEKNIMED Recent Developments
5 Global Synthetic Bone Graft Substitute Syringe Market Scenario by Region
- 5.1 Global Synthetic Bone Graft Substitute Syringe Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Synthetic Bone Graft Substitute Syringe Sales by Region: 2021-2032
- 5.2.1 Global Synthetic Bone Graft Substitute Syringe Sales by Region: 2021-2026
- 5.2.2 Global Synthetic Bone Graft Substitute Syringe Sales by Region: 2027-2032
- 5.3 Global Synthetic Bone Graft Substitute Syringe Revenue by Region: 2021-2032
- 5.3.1 Global Synthetic Bone Graft Substitute Syringe Revenue by Region: 2021-2026
- 5.3.2 Global Synthetic Bone Graft Substitute Syringe Revenue by Region: 2027-2032
- 5.4 North America Synthetic Bone Graft Substitute Syringe Market Facts & Figures by Country
- 5.4.1 North America Synthetic Bone Graft Substitute Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Synthetic Bone Graft Substitute Syringe Sales by Country (2021-2032)
- 5.4.3 North America Synthetic Bone Graft Substitute Syringe Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Synthetic Bone Graft Substitute Syringe Market Facts & Figures by Country
- 5.5.1 Europe Synthetic Bone Graft Substitute Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Synthetic Bone Graft Substitute Syringe Sales by Country (2021-2032)
- 5.5.3 Europe Synthetic Bone Graft Substitute Syringe Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Synthetic Bone Graft Substitute Syringe Market Facts & Figures by Country
- 5.6.1 Asia Pacific Synthetic Bone Graft Substitute Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Synthetic Bone Graft Substitute Syringe Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Synthetic Bone Graft Substitute Syringe Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Synthetic Bone Graft Substitute Syringe Market Facts & Figures by Country
- 5.7.1 South America Synthetic Bone Graft Substitute Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Synthetic Bone Graft Substitute Syringe Sales by Country (2021-2032)
- 5.7.3 South America Synthetic Bone Graft Substitute Syringe Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Synthetic Bone Graft Substitute Syringe Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Synthetic Bone Graft Substitute Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Synthetic Bone Graft Substitute Syringe Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Synthetic Bone Graft Substitute Syringe Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Synthetic Bone Graft Substitute Syringe Sales by Type (2021-2032)
- 6.1.1 Global Synthetic Bone Graft Substitute Syringe Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Synthetic Bone Graft Substitute Syringe Sales Market Share by Type (2021-2032)
- 6.2 Global Synthetic Bone Graft Substitute Syringe Revenue by Type (2021-2032)
- 6.2.1 Global Synthetic Bone Graft Substitute Syringe Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Synthetic Bone Graft Substitute Syringe Revenue Market Share by Type (2021-2032)
- 6.3 Global Synthetic Bone Graft Substitute Syringe Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Synthetic Bone Graft Substitute Syringe Sales by Application (2021-2032)
- 7.1.1 Global Synthetic Bone Graft Substitute Syringe Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Synthetic Bone Graft Substitute Syringe Sales Market Share by Application (2021-2032)
- 7.2 Global Synthetic Bone Graft Substitute Syringe Revenue by Application (2021-2032)
- 7.2.1 Global Synthetic Bone Graft Substitute Syringe Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Synthetic Bone Graft Substitute Syringe Revenue Market Share by Application (2021-2032)
- 7.3 Global Synthetic Bone Graft Substitute Syringe Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Synthetic Bone Graft Substitute Syringe Value Chain Analysis
- 8.1.1 Synthetic Bone Graft Substitute Syringe Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Synthetic Bone Graft Substitute Syringe Production Mode & Process
- 8.2 Synthetic Bone Graft Substitute Syringe Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Synthetic Bone Graft Substitute Syringe Distributors
- 8.2.3 Synthetic Bone Graft Substitute Syringe Customers
9 Global Synthetic Bone Graft Substitute Syringe Analyzing Market Dynamics
- 9.1 Synthetic Bone Graft Substitute Syringe Industry Trends
- 9.2 Synthetic Bone Graft Substitute Syringe Industry Drivers
- 9.3 Synthetic Bone Graft Substitute Syringe Industry Opportunities and Challenges
- 9.4 Synthetic Bone Graft Substitute Syringe Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst